Kristensen, Lars Erik
Keiserman, Mauro
Papp, Kim http://orcid.org/0000-0001-9557-3642
McCasland, Leslie
White, Douglas http://orcid.org/0000-0003-0839-8511
Carter, Kyle
Lippe, Ralph
Photowala, Huzefa
Drogaris, Leonidas
Soliman, Ahmed M.
Chen, Michael
Padilla, Byron
Behrens, Frank http://orcid.org/0000-0001-8750-7186
Article History
Received: 9 January 2024
Accepted: 13 February 2024
First Online: 18 March 2024
Declarations
:
: Lars Erik Kristensen has received honoraria or fees for serving as a speaker or consultant from AbbVie, Amgen, Biogen, Bristol Myers Squibb, Gilead, Janssen, Lilly, Merck, Novartis, Pfizer, and UCB. He has also received IIT research grants from Lilly, Novartis, Pfizer, and UCB. Mauro Keiserman has served as a speaker for AbbVie, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, and UCB; was a consultant for AbbVie, Bristol Myers Squibb, GlaxoSmithKline, MSD, Biogen, Sanofi, and Novartis; and receives grant/research support from AbbVie, Bristol Myers Squibb, GlaxoSmithKline, MSD, Biogen, Sanofi, and Novartis. Kim Papp has received research funds from AbbVie, Aceleryn, Amgen, Arcutis, Bausch Health, Baxalta, Boehringer Ingelheim, Bristol Myers Squibb, Coherus, Dermavant, Forward Pharma, Galderma, Incyte, Janssen, LEO Pharma, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, Sun Pharma, and UCB. He is a consultant for AbbVie, Aceleryn, Amgen, Arcutis, Astellas, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Coherus, Dermavant, Forward Pharma, Galderma, Incyte, Janssen, LEO Pharma, Lilly, Meiji Seika Pharma, Merck, Mitsubishi Tanabe Pharma, Novartis, Pfizer, Sandoz, Sanofi Genzyme, Stiefel, Sun Pharma, Takeda, and UCB. He is a speaker for AbbVie, Amgen, Arcutis, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Incyte, Janssen, LEO Pharma, Lilly, Novartis, Pfizer, Sandoz, Sanofi Genzyme, Sun Pharma, and UCB. He is a committee member for PSOLAR (Psoriasis Longitudinal Assessment and Registry) and PURE (registry of patients with moderate-to-severe chronic plaque psoriasis in Latin America and Canada). Leslie McCasland has received fees for serving on an advisory board from Lilly. Douglas White has received honoraria or fees for serving on advisory boards or as a speaker or consultant from AbbVie. Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Michael Chen, and Byron Padilla are full-time employees of AbbVie, and may hold AbbVie stock or stock options. Ahmed M. Soliman is a full-time employee of AbbVie, may hold AbbVie stock or stock options, and is a coinventor on AbbVie patents. Frank Behrens has received research grants, honoraria, or fees for serving as a consultant or speaker from AbbVie, Amgen, Affibody, Acelyrin, BMS, Boehringer Ingelheim, Chugai, Celltrion, Galapagos, Genzyme, Gilead, GlaxoSmithKline, Janssen, Lilly, Merck, MoonLake, Novartis, Pfizer, Roche, Sandoz and Sanofi.
: The study protocol, informed consent forms, and recruitment materials were approved by the independent ethics committee or institutional review board at each study site before patient enrollment began (Supplementary Table 1). The studies were conducted in accordance with the International Conference for Harmonisation guidelines, applicable regulations, and the Declaration of Helsinki. All patients provided written informed consent before entering the study.